129
Participants
Start Date
February 25, 2013
Primary Completion Date
November 2, 2016
Study Completion Date
July 13, 2017
ombitasvir/paritaprevir/ritonavir and dasabuvir
Tablet; ombitasvir coformulated with paritaprevir and ritonavir, dasabuvir tablet
ombitasvir/paritaprevir/ritonavir
Tablet; ombitasvir coformulated with paritaprevir and ritonavir
ribavirin
tablet
Lead Sponsor
AbbVie
INDUSTRY